StartUPDATES: New developments from healthcare startups - MedCity News

light bulb, innovation, idea

Provider of health data exchange solutions, Opal, announced the commercial availability of its attribution API that streamlines the delivery of value-based care to patients in a way that delivers significant administrative efficiencies and improves reimbursement for providers. In tandem, the company announced the first implementation of this solution in MultiCare Connected Care.

Designed in partnership with MultiCare in Washington State and health insurance provider in various states Washington State and AlaskaThe API uses the Health Level Seven (HL7) Fast Healthcare Interoperability Resources (FHIR) standard to identify which patients are part of value-based care contracts and ensure that providers and payers have complete patient information in real time.

Historically, comparing patient lists of value-based contracts to those in provider files has been a time-consuming, error-prone manual process overly reliant on Word documents or Excel spreadsheets to share information. Without clear visibility into patient coverage, providers are often unsure which patients are eligible for comprehensive and preventive care.

“Provider and payer organizations have spent the last 25 years trying to figure out how to unlock the promise of value-based contracting. today, Opal achieved that goal,” said Opal CEO Ken Chandler. “Our attribution API uses FHIR standards to automate the sharing of information between payers and providers, providing member data that is accurate and accessible in real-time in a scalable format so that it can be easily applied to any provider or payer organization.’

Wheel has acquired GoodRxvirtual health technology business as part of a $19.5 million digital health infrastructure licensing deal, first reported by Axios. According to an SEC filingGoodRx will continue to provide its users with access to telehealth services through the GoodRx Care platform using Wheel’s technology and staffing services.

To learn more Press here.

I see throughan automated medical coding startup launched in 2017 has closed a $46 million Series B funding round. Alkeon Capital and Lightspeed Venture Partners led the round with participation from Cedars-Sinai, Vituity’s Inflect Health, ApolloMD, as well as existing investors Founders Fund and Tarsadia.

Galim ImanbaevMD, Partner at Lightspeed, and Mark McLaughlin, general partner at Alkeon Capital, will join Fathom’s board of directors. The Series B round brings Fathom’s total funding to $61 million.

“Widespread autonomous medical coding is one of the first steps toward rebuilding America’s healthcare payment system into something that actually works for providers, payers and patients,” said Andrew Lockhart, CEO and co-founder of Fathom. “With inflation and severe staffing shortages driving up costs at a time when revenues are shrinking, automation has become a critical lever for ensuring the financial sustainability of our healthcare system. This funding will allow us to radically expand the number of specialties and health systems we support.”

To learn more Press here.

Tivic Health Systemsa commercial-stage health technology company focused on bioelectronic medicine will exhibit at HTLH conference with ClearUP, an FDA-approved and clinically proven device that uses low-level electrical stimulation to treat sinus pain and congestion. Tivic is exhibiting in the UCSF Health Hub Pavilion booth #1158-33. HLTH will be held November 13-16 at the Venetian Expo in Las Vegas.

“Our key goals are to increase consumer awareness of bioelectronic therapies and develop these non-invasive, drug-free technologies to become mainstream treatment options for common health conditions,” said Blake Gurfein, Chief Scientific Officer of Tivic Health. “The use of bioelectronic medicine to address various conditions has increased in recent years and is expected to continue to expand its scope and commercial appeal in the near future. We intend to continue to pioneer bioelectronic medicine research and develop a trusted brand that builds and delivers evidence-based, safe and effective bioelectronic therapies.”

To learn more Press here.

Digital health is transforming the medical technology sector as well as consumption trends, according to a new report from Accenture and AdvaMed. The report – “Digital health and medical technology — new signals of transformation, is based on a global survey of more than 150 medical technology executives. It highlights a shift away from traditional healthcare models, with leaders embracing digital healthcare as part of their approach to improving patient outcomes.

“Healthcare is at a crossroads, facing unprecedented pressures and disruptions – including affordability challenges, changing patient expectations and an increasing flow of health data,” said Tim Durst, managing director at Accenture, who leads the global medical technology sector in the life of the Scientific Practice company. “With a unique understanding of therapeutics, patients and providers, and the insights gained from digital devices in the hands of patients, MedTech companies are well positioned to lead the transformation to digital healthcare.” However, companies will need the right digital foundation to take advantage of the necessary insights and create a complete digital health solution.”

To read more, Press here.

photo: ipopba, Getty Images

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *